“…In this study, IP-10 classified 56% CXCL: chemokine (C-X-C motif) ligand; IL: interleukin; MIG: monokine induced by interferon-c; IP-10: interferon-c-induced protein 10; MCP: monocyte chemotactic protein; MIP: macrophage inflammatory protein; IFN: interferon; TNF: tumour necrosis factor; EGF: epidermal growth factor; TGF: transforming growth factor; VEGF: vascular endothelial growth factor; sCD40L: soluble CD40 ligand; IL-1RA: IL-1 receptor antagonist. Several markers showed no or only little diagnostic potential including GRO (CXCL1) [60], stromal cell-derived factor 1 (CXCL12) [97], Fractalkine (CXC3CL1) [65,89], I-309 (chemokine (C-C motif) ligand (CCL) 1) [97], regulated on activation, normal T-cell expressed and secreted (CCL5) [62,69,86], eotaxin (CCL11) [62,65,69] [70] explored the diagnostic potential using ESAT-6/CFP10 stimulated PBMCs, and found it less sensitive for active tuberculosis compared to IFN-c; similar results were recently shown in a whole blood model [62]. Other studies demonstrated comparable performance to IP-10 and IFN-c in patients with active tuberculosis compared to controls [67] and in healthcare workers with presumed LTBI [69].…”